Vyndamax 61 MG capsule UD 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FB9UN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,593
Award facts
- Contract value 100% obligated
- $14,592.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,592.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp on February 4, 2026, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count). This delivery order is a non-set-aside contract with an ultimate completion date of February 26, 2026, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, has demonstrated consistent capability to meet government requirements through open competition. The company supplies a comprehensive range of pharmaceutical products to federal agencies including the Department of Defense and Defense Health Agency. This particular delivery order for Vyndamax, a cardiovascular medication used in the treatment of transthyretin cardiac amyloidosis, reflects the company's ongoing role in providing specialized pharmaceutical commodities across multiple therapeutic domains to support military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FB9UN?
SPE2DR26FB9UN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FB9UN worth?
The government has obligated $14,593 on SPE2DR26FB9UN.
Is contract SPE2DR26FB9UN an order under another contract?
Yes. SPE2DR26FB9UN is a delivery order under SPE2DR25D2212, an indefinite delivery contract.
Was contract SPE2DR26FB9UN competed?
The extent of competition for SPE2DR26FB9UN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award